ThreoTech LLC settles patent infringement lawsuit on Magtein magnesium L-threonate

News
Article

ThreoTech LLC has announced that it has reached a confidential settlement with Green Jeeva to end a patent infringement lawsuit regarding Magtein magnesium L-threonate.

Photo © iStockphoto.com/KLH49

Photo © iStockphoto.com/KLH49


ThreoTech LLC has announced that it has reached a confidential settlement with Green Jeeva to end a patent infringement lawsuit regarding Magtein magnesium L-threonate. The lawsuit was originally filed on August 15, 2024 in the Central District of California.

“Magtein is a unique dietary supplement ingredient protected by a variety of composition and use patents,” said Edward Lee, CEO of ThreoTech, LLC, in a press release. “Our patent portfolio and other intellectual property supporting Magtein magnesium L-threonate is strong. We stand ready to protect our intellectual property.”

ThreoTech LLC is the exclusive licensee of a portfolio of patents owned by Neurocentria Inc. Magtein has been shown in research to support sleep and cognitive health.

Recent Videos
woman working on laptop computer by window
Related Content
© 2025 MJH Life Sciences

All rights reserved.